Lipidomic-Based Advances in Diagnosis and Modulation of Immune Response to Cancer
While immunotherapies for diverse types of cancer are effective in many cases, relapse is still a lingering problem. Like tumor cells, activated immune cells have an anabolic metabolic profile, relying on glycolysis and the increased uptake and synthesis of fatty acids. In contrast, immature antigen...
Main Authors: | Luis Gil-de-Gómez, David Balgoma, Olimpio Montero |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/10/8/332 |
Similar Items
-
Lipidomics Issues on Human Positive ssRNA Virus Infection: An Update
by: David Balgoma, et al.
Published: (2020-08-01) -
Lipidomics Identified Lyso-Phosphatidylcholine and Phosphatidylethanolamine as Potential Biomarkers for Diagnosis of Laryngeal Cancer
by: Bo Yu, et al.
Published: (2021-06-01) -
Advancing Semen Evaluation Using Lipidomics
by: Holly C. Evans, et al.
Published: (2021-04-01) -
Lipidomic Response to Coffee Consumption
by: Alan Kuang, et al.
Published: (2018-12-01) -
Lipidomics unveils the complexity of the lipidome in metabolic diseases
by: Todd A. Lydic, et al.
Published: (2018-01-01)